Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial
Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page
- Check5 days agoChange DetectedDifference0.3%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.4%
- Check63 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on lupus nephritis and IgAN, while adding new information about participant masking and a new version revision.SummaryDifference15%
- Check70 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 23, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.4%
Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.